Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 92.59
(-0.42%)
CNY 92.59
(-0.42%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 573.85 Million CNY | 28.13% |
| 2022 | 415.21 Million CNY | 14.45% |
| 2021 | 362.77 Million CNY | 45.15% |
| 2020 | 249.93 Million CNY | 52.15% |
| 2019 | 164.26 Million CNY | 56.67% |
| 2018 | 104.84 Million CNY | 41.83% |
| 2017 | 73.92 Million CNY | 64.8% |
| 2016 | 44.85 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 239.12 Million CNY | 16.29% |
| 2024 Q1 | 205.62 Million CNY | 89.46% |
| 2024 Q3 | 64.22 Million CNY | -30.98% |
| 2023 Q4 | 108.53 Million CNY | -13.84% |
| 2023 Q3 | 125.96 Million CNY | -31.06% |
| 2023 Q2 | 182.72 Million CNY | 26.43% |
| 2023 FY | 532.01 Million CNY | 28.13% |
| 2023 Q1 | 144.52 Million CNY | 118.91% |
| 2022 Q2 | 109.08 Million CNY | -22.86% |
| 2022 Q1 | 141.4 Million CNY | 100.55% |
| 2022 Q3 | 98.69 Million CNY | -9.53% |
| 2022 FY | 415.21 Million CNY | 14.45% |
| 2022 Q4 | 66.02 Million CNY | -33.11% |
| 2021 Q3 | 76.6 Million CNY | -21.04% |
| 2021 Q4 | 70.51 Million CNY | -7.96% |
| 2021 FY | 362.77 Million CNY | 45.15% |
| 2021 Q2 | 97.02 Million CNY | -18.22% |
| 2021 Q1 | 118.63 Million CNY | 97.31% |
| 2020 Q2 | 71.49 Million CNY | 2.92% |
| 2020 Q1 | 69.47 Million CNY | 107.61% |
| 2020 FY | 249.93 Million CNY | 52.15% |
| 2020 Q4 | 60.12 Million CNY | 23.11% |
| 2020 Q3 | 48.83 Million CNY | -31.7% |
| 2019 Q3 | 31.96 Million CNY | -31.45% |
| 2019 Q2 | 46.62 Million CNY | -10.71% |
| 2019 Q1 | 52.21 Million CNY | 239.22% |
| 2019 FY | 164.26 Million CNY | 56.67% |
| 2019 Q4 | 33.46 Million CNY | 4.7% |
| 2018 Q1 | 38.29 Million CNY | 0.0% |
| 2018 FY | 104.84 Million CNY | 41.83% |
| 2018 Q4 | 15.39 Million CNY | -15.96% |
| 2018 Q3 | 18.31 Million CNY | -44.24% |
| 2018 Q2 | 32.84 Million CNY | -14.21% |
| 2017 FY | 73.92 Million CNY | 64.8% |
| 2016 FY | 44.85 Million CNY | 0.0% |